HIV-associated cryptococcal meningitis
JN Jarvis, TS Harrison - Aids, 2007 - journals.lww.com
While the incidence of cryptococccal meningitis in the developed world has declined with
widespread, early antiretroviral therapy (ART), cryptococcal disease remains a major …
widespread, early antiretroviral therapy (ART), cryptococcal disease remains a major …
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for …
A Loyse, D Wilson, G Meintjes, JN Jarvis… - Clinical infectious …, 2012 - academic.oup.com
Abstract (See the Editorial Commentary by Bennett, on pages 129–30.) Background. HIV-
associated cryptococcal meningitis is associated with an estimated 600 000 deaths …
associated cryptococcal meningitis is associated with an estimated 600 000 deaths …
Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus
LA Tell, KV Clemons, Y Kline, L Woods… - Medical …, 2010 - academic.oup.com
Aspergillus fumigatus causes disease in birds. Our objectives were to determine
pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel …
pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng, Y Lu… - BMC Infectious …, 2022 - Springer
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective …
J Liu, J Liu, X Su, L Yang, Y Wang, A Wang, X Xu, M Li… - BMC neurology, 2022 - Springer
Background Our previous study explored Amphotericin B (AMB) plus 5-flucytosine (5-FC)
combined with fluconazole (FLU) therapy in the induction period, which seemed to be better …
combined with fluconazole (FLU) therapy in the induction period, which seemed to be better …
Effects of Double and Triple Combinations of Antifungal Drugs in a Murine Model of Disseminated Infection by Scedosporium prolificans
We have evaluated the efficacies of micafungin, amphotericin B, and voriconazole, alone
and in double and triple combinations, in a murine model of systemic infection by …
and in double and triple combinations, in a murine model of systemic infection by …
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant …
We present 2 cases of HIV-related cryptococcal meningitis, persisting after 3 and 9 months,
respectively, of standard treatment. Both patients were treated successfully with a salvage …
respectively, of standard treatment. Both patients were treated successfully with a salvage …
Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment
H Zhao, Y Lu, S Li, J Qin, M Xu, H Ye, Z Yang, J Rao… - Mycoses, 2024 - Wiley Online Library
Background The efficacy and side effects of voriconazole plus 5‐flucytosine (Vori+ 5‐FC)
versus amphotericin B deoxycholate plus 5‐flucytosine (AmBd+ 5‐FC) as an induction …
versus amphotericin B deoxycholate plus 5‐flucytosine (AmBd+ 5‐FC) as an induction …
Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis
C de Castro Spadari, FWM da Silva de Bastiani… - Archives of …, 2020 - Springer
Cryptococcosis is a common opportunistic infection in patients with advanced HIV infection
and may also affect immunocompetent patients. The available antifungal agents are few and …
and may also affect immunocompetent patients. The available antifungal agents are few and …
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin
The present study developed Galleria mellonella and murine infection models for the study
of Trichosporon infections. The utility of the developed animal models was demonstrated …
of Trichosporon infections. The utility of the developed animal models was demonstrated …